McMaster University in Hamilton, Ontario, has unveiled its newly expanded Nuclear Research Building, which includes a new cyclotron facility and improvements to the McMaster Nuclear Reactor (MNR) Building.

The Quebec College of Physicians will re-read 4,500 mammograms from three clinics based on the recommendations of two medical investigators.

The FDA has approved Toshiba America Medical Systems' HDR-08A Imaging System for Kalare, which is an updated version of its Kalare R&F.

Ronald Petersen, MD, director of the Mayo Alzheimers Disease Research Center and the Mayo Clinic Study of Aging, was selected to chair the Advisory Council on Alzheimers Research, Care and Services. The formation of the group was announced Aug. 23 by the U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius.

Elevated levels of cathepsin S, a protein biomarker, in elderly patients increased the risk of death and was linked to the development of cardiovascular disease and cancer, according to data presented Aug. 30 at the European Society of Cardiology Congress in Paris and simultaneously published in the Journal of the American Medical Association.

A new study has found that a soil and seed approach may offer a simple and effective treatment for patients with metastatic solid tumors of visceral organs such as the liver, kidney, lung and brain. The study is published in the September issue of Radiology.

Linagliptin, Boehringer Ingelheim Pharmaceuticals and Eli Lillys 5 mg drug used to treat type 2 diabetes, has received approval from the European Commission. The drug, marketed as Tradjenta, is approved for use in combination with metformin and metformin plus sulfonylurea.

Two decades of experts calling for value in Medicare reimbursement has gone largely unheeded. However, transitioning toward value-based reimbursement for imaging could optimize innovation and reward advances that deliver improved health and economic outcomes, according to an article published in the September issue of Academic Radiology.